Ixico Share Discussion Threads

[citys2874] 06/6/2024 15:26

yep this is now heading higher tomorrow and over the next few weeks

[chrisdgb] 06/6/2024 09:23

The bar is now set so low, contract news will help.......

[citys2874] 03/6/2024 08:20

i have called many multi-baggers and bottom has been found and we are ready to push up simple....i do the technical analysis and its a BUY from me

[pennyfalls] 28/5/2024 19:29

Yeah Citys, sure!!
I often wonder whether moronic ramping like this ever has an effect.
I see he’s trying ot across boards.
Desperate

[citys2874] 28/5/2024 10:55

good buying pressure coming in today mms ready to lift share price higher

[40 fathoms] 25/5/2024 11:05

Contract delays in the CNS space are very much a fact and not IXI specific, you can see this in the outlook statements of their peers.

IXI have really backed themselves in to corner with their reckless spending on just about everything over the past 5 years. insane salaries, undisciplined R&D spending, overstaffing, a useless board. This is now coming back to plague them.

Even if they win significant numbers of large contracts in the next 6 months they do not have sufficient working capital to be certain they can execute. This will also impact sponsors confidence to contract with them. They need an additional 2-3 million cash to correct this situation.

In truth the best outcome for existing shareholders is for the board to conduct a process and sell the business. Of course they won't do that, they will tap the market for cash equivalent to 60% to 80% of the current market cap. Almost doubling the share count in the process. On the plus side they have many on the register that can stand their round, on the negative side any CR does not necessarily, permanently, fix the problem.

One point in the IMC prevention where I think they are being a bit disingenuous is with respect to the balance of their contract book. They have pointed to the shift from large late stage trials to smaller early stage trials. While it is true this reduces their risk to any individual trial descope or cancellation, what they have not mentioned is the huge failure rate for early stage CNS trials. Although it is improving, it has historically been about 95% for phase I CNS trials. So having early stage trials can lead to large later stage trials, the probability of any individual trial progressing to a later stage is very, very low.

[red ninja] 23/5/2024 15:05

Isn't this heading for a cash raising ?

[dillydally2] 23/5/2024 14:30

Down the toilet

[citys2874] 23/5/2024 09:13

was 14.00 6 months ago so cheap now and great time to buy

[citys2874] 23/5/2024 07:24

Great win - good blue opening start

[citys2874] 23/5/2024 07:13

RNS OUT - Awesome news £2 million contract win ....can we see 10.00+

[chrisdgb] 23/5/2024 07:06

Nice to see contract news......

[chrisdgb] 21/5/2024 07:38

Maybe being too optimistic but I sniff a recovery here......

[chrisdgb] 13/3/2024 08:41

Some kind of industry investor would be a nice option, as a result of a contract..?

[40 fathoms] 13/3/2024 07:58

Patience and CASH. Drawdown in cash highlighted in today's TU means it is getting critical and hard to see now how they will be able to avoid a CR.

[chrisdgb] 08/3/2024 10:38

Looks like patience required here.....

[casholaa] 16/2/2024 11:38

"Ixico PLC - London-based precision analytics company working to advance investigational therapies for neurological diseases - Revenue for the year that ended on September 30 falls 23% to GBP6.7 million from GBP8.6 million the year before. Company swings to GBP1.4 million pretax loss following a GBP885,000 profit. Total operating expenses increase to GBP5.1 million from GBP5.0 million. Ixico says revenue drop was expected and caused by the now-realised impact of clients ceasing multiple large "failed" trials across 2021 and early 2022. Expects to deliver roughly flat revenue in the current financial year before returning to growth in 2025."

[chrisdgb] 16/2/2024 10:42

Well this is fun.............

[40 fathoms] 27/1/2024 12:35

Well Giulio is going, it was clear all the fight had gone out of him so it is not a huge surprise as he has not been very effective but has been very, very expensive. It is going to take a year for him to leave and there will have to overlap with another expensive (but hopefully less so) CEO, so there will be double costs for a while.

CFO also needs to be replaced with one that costs half as much and then you would have clean foundations and things can start to look a lot better. Also, unless they are able to sign some large, new, contracts and or cut their R&D spend very soon then they are going to need more cash.

With the right CEO and a much less ambitions strategy it would not be hard to get to a position where it is making a sustanible EBIT of GBP 2 or GBP 3 million per year. That is worth a share price of 50p in my view, provided they do not increase the share count. They also need to give up on AD and ARIA as they are not in the race. Double down on Huntingdon's and pick up the focus on some of the other less competitive CNS indications.

If we see this or a similar strategy put in place then I am a buyer. If this does not happen this is going to bump around between 8p and 15p for as far as the eye can see.

[up4itt] 26/1/2024 04:22

The selling is attributable to the fact that I had just bought in prior to the drop in the share price. The correlation seldom fails.

[chrisdgb] 25/1/2024 16:01

Is this AGM related selling?? Did they make comments??

[jimtech] 08/12/2023 11:02

Guilio was obviously frustrated with the "harsh" lowly company valuation.
But then there is not much to get excited about if they are expecting a flat 2024 so share price may well sink further.
I thought the fundraising comments were theoretical but you are right, as you point out, they were not dismissed out of hand.

[40 fathoms] 07/12/2023 23:43

Gosh the IMC Company call was downbeat, Giulio is normally so enthusiastic but he came across as totally disinterested, it was almost like he has already checked out. Based on this performance I would not be surprised to see him move on in the near future.

I was also a bit shocked to hear them say we are thinking about raising capital rather than the usual we have no need for capital, which based on my reading of the balance sheet would appear to be the case for the foreseeable term.